Statistics for Characterization of TRIB2 mediated drug resistance and its validation as a novel diagnostic marker
Total visits
| views | |
|---|---|
| Characterization of TRIB2 mediated drug resistance and its validation as a novel diagnostic marker | 61 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 2 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| sm_tese.pdf(legacy) | 41 |
| sm_tese.pdf | 36 |
Top country views
| views | |
|---|---|
| Portugal | 22 |
| United States | 12 |
| Spain | 6 |
| Canada | 4 |
| China | 4 |
| United Kingdom | 4 |
| Hong Kong SAR China | 3 |
| Australia | 2 |
| Germany | 2 |
| Iran | 2 |
| Bangladesh | 1 |
| Switzerland | 1 |
| Ireland | 1 |
| India | 1 |
| South Korea | 1 |
| Poland | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Barcelona | 4 |
| Faro | 2 |
| Moncarapacho | 2 |
| Lagos | 1 |
| Lisbon | 1 |
| Madrid | 1 |